Skip to main content

SOLENO THERAPEUTICS INC (SLNO) Stock Forecast


Stock Price Forecast

July 17, 2025


Forecasted Returns

7 Days Predict

30 Days Predict

90 Days Predict


Forecasted Market-Excess Returns

7 Days Predict

30 Days Predict

90 Days Predict

Loading SOLENO THERAPEUTICS INC chart...

About the Company

We do not have any company description for SOLENO THERAPEUTICS INC at the moment.

Exchange

Nasdaq

$0M

Total Revenue

27

Employees

$4B

Market Capitalization

-18.46

Price/Earning ratio

Fundamental Data and Insider Transactions (Quarterly data) Full Screen

Loading the fundamentals chart...

Latest News on SOLENO THERAPEUTICS INC

Down 21.7% in 4 Weeks, Here's Why Soleno Therapeutics (SLNO) Looks Ripe for a Turnaround

2d ago, source: None

Soleno Therapeutics, Inc. (SLNO) has been on a downward spiral lately with significant selling pressure. After declining 21.7 ...

Soleno Under Serious Scrutiny As Short Seller Alleges PWS Drug Is Overpriced, Unsafe

6d ago, source: Benzinga

Children were reportedly hospitalized after starting treatment. Scorpion Capital suggests Soleno's medication could face ...

Soleno Therapeutics Stock Slumps After Scorpion Capital Reveals Short Position: But Retail’s Not Pessimistic Yet

6d ago, source: None

Shares of Soleno Therapeutics (SLNO) slumped 7% on Friday afternoon after Scorpion Capital revealed a short position on the stock, citing risks associated with the company’s drug approved for ...

Soleno Therapeutics stock falls after Scorpion Capital short report

6d ago, source: Yahoo Finance

Soleno Therapeutics Inc (NASDAQ:SLNO) stock fell 13% Friday morning following a short report from Scorpion Capital that raised serious concerns about the company’s recently approved Prader-Willi ...

Soleno Therapeutics, Inc. (NASDAQ:SLNO) Receives $108.70 Consensus ...

16d ago, source: ETF Daily News

Soleno Therapeutics has a 12 month low of $41.50 and a 12 month high of $90.32. The company has a market capitalization of $4.11 billion, a price-to-earnings ratio of -17.67 and a beta of -2.56.

Soleno Therapeutics, Inc. (SLNO) Reports Q2 Loss, Tops Revenue Estimates

15d ago, source: None

Soleno Therapeutics (SLNO) delivered earnings and revenue surprises of +83.02% and +1.58%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

Soleno Therapeutics, Inc. to Participate in February Investor ...

6mon ago, source: Nasdaq

Soleno Therapeutics, Inc. announced its participation in two upcoming investor conferences in February 2025. The company will host a fireside chat at the Guggenheim SMID Cap Biotech Conference on ...

Soleno Therapeutics, Inc. Announces $200 Million Public ... - Nasdaq

1mon ago, source: Nasdaq

Soleno Therapeutics, Inc. announced its plan to conduct a public offering for $200 million in shares of its common stock, with an option for underwriters to purchase an additional $30 million in ...

Charles Schwab Investment Management Inc. Buys 24,953 Shares of Soleno ...

5mon ago, source: ETF Daily News

Soleno Therapeutics, Inc. has a one year low of $36.61 and a one year high of $60.92. The firm has a market capitalization of $2.25 billion, a price-to-earnings ratio of -14.79 and a beta of -1.70.

Why Soleno Therapeutics Inc. (SLNO) Surged On Thursday?

4mon ago, source: Insider Monkey

Soleno Therapeutics Inc. (NASDAQ:SLNO) Soleno Therapeutics jumped by 37.61 percent on Thursday to end at $67.39 apiece as investors cheered news that it secured the approval of the Food and Drug ...

Soleno Therapeutics Announces Sale of Non-Strategic Assets to Flexicare ...

8y ago, source: Business Insider

REDWOOD CITY, Calif., July 24, 2017 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (NASDAQ:SLNO), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of rare ...

Similar Companies
Company Ticker 90 Days Forecast Market Cap. (USD M) P/E P/B
Axogen, Inc. AXGN Predict 683.28 -41.70 6.09
BIOLIFE SOLUTIONS INC BLFS Predict 990.70 -14.65 2.81
BioSig Technologies, Inc. BSGM Predict 126.37 -1.82 48.51
Ceribell, Inc. CBLL Predict 450.54 None 2.62
CONMED Corp CNMD Predict 1673.88 15.19 1.67
CUTERA INC CUTR Predict 9.08 -0.06 -0.04
CapsoVision, Inc CV Predict -0.32 None None
electroCore, Inc. ECOR Predict 39.09 -7.26 35.12
EDAP TMS SA EDAP Predict 55.15 None 1.35
Electromed, Inc. ELMD Predict 170.00 23.74 3.87
FONAR CORP FONR Predict 95.72 9.22 0.61
GUIDED THERAPEUTICS INC GTHP Predict 21.72 None None
HELIUS MEDICAL TECHNOLOGIES, INC. HSDT Predict 66.46 -0.04 51.92
Hyperfine, Inc. HYPR Predict 147.70 -1.83 0.89
InMode Ltd. INMD Predict 1146.49 None 1.63
IRIDEX CORP IRIX Predict 19.00 -2.75 3.14
IR-Med, Inc. IRME Predict 1.37 None None
Integer Holdings Corp ITGR Predict 3844.56 46.51 2.26
LivaNova PLC LIVN Predict 2911.03 -662.01 2.59
MASIMO CORP MASI Predict 7918.78 128.12 7.59
Medtronic plc MDT Predict 118077.57 25.33 2.46
Movano Inc. MOVE Predict 5.42 -8.57 0.74
ENDRA Life Sciences Inc. NDRA Predict 1.92 -0.78 1.10
Neuraxis, INC NRXS Predict 23.76 -0.86 5.59
Nuwellis, Inc. NUWE Predict 64.73 -0.06 18.09
Nexalin Technology, Inc. NXL Predict 13.66 -4.68 2.29
Nexalin Technology, Inc. NXLIW Predict 4.77 None 0.96
Outset Medical, Inc. OM Predict 236.11 -0.41 1.52
PRECISION OPTICS CORPORATION, INC. POCI Predict 36.49 -11.54 2.77
QT IMAGING HOLDINGS, INC. QTI Predict 7.20 -0.42 -0.75
SOLENO THERAPEUTICS INC SLNO Predict 4416.52 -18.46 19.02
Semler Scientific, Inc. SMLR Predict 463.22 12.50 1.21
STAR EQUITY HOLDINGS, INC. STRR Predict 6.87 -1.60 0.11
STAR EQUITY HOLDINGS, INC. STRRP Predict 30.45 -5.50 0.49
Stereotaxis, Inc. STXS Predict 1112.32 -8.43 763.96
Tivic Health Systems, Inc. TIVC Predict 3.66 -0.03 0.99
TransMedics Group, Inc. TMDX Predict 4780.74 66.71 15.03
Vivani Medical, Inc. VANI Predict 91.83 -2.67 7.90
VASO Corp VASO Predict 22.85 20.10 0.86
ZYNEX INC ZYXI Predict 47.01 41.41 37.28

Latest Neutral (free) Forecasts

STRONG BUY BUY NEUTRAL SELL STRONG SELL ALL

Loading the latest forecasts...

My Portfolio

Investment Dashboard

Loading your portfolio...